As of June 26th, 2023, Shenzhen Dakewei Biotechnology Co., Ltd. listed the New Third Board from July 20th16th to February 20th19th. Due to the update of financial information, the company applied to suspend the listing review procedure, which has not been resumed yet. As long as the follow-up company procedures meet the requirements, enterprises can still go public.